NDC 51662-1410
PYRIDOXINE HCI
Pyridoxine Hci
PYRIDOXINE HCI is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Pyridoxine Hydrochloride.
| Product ID | 51662-1410_946c8e50-08d1-755d-e053-2a95a90a84de |
| NDC | 51662-1410 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PYRIDOXINE HCI |
| Generic Name | Pyridoxine Hci |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2019-10-08 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA080618 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | PYRIDOXINE HYDROCHLORIDE |
| Active Ingredient Strength | 100 mg/mL |
| Pharm Classes | Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |